Presseinformationen weltweit an Journalisten und Leser verbreiten
Die Pharmaindustrie unterliegt einem stetigen Wandel. Insbesondere die Roh- und Wirkstoffproduktion wurde im letzten Jahrzehnt zunehmend in Länder verlagert, in denen kostengünstiger produziert werden kann. So wurde die Auslagerung an externe Auftragshersteller, so genannte Contract Manufacturing Organizations (CMO) zunehmend beliebter. Mehr
The pharmaceutical industry is subject to constant change. In the last decade, the production of raw materials and active ingredients in particular has increasingly been relocated to countries where production can be carried out in a more cost-effective manner. Outsourcing Mehr
Ungefähr jeder siebte Mensch, der in ein Krankenhaus kommt, benötigt eine Blutspende. Ein Liter Blut kann dabei bis zu drei Leben retten. Leider spenden während der Coronavirus-Pandemie nicht genug Menschen Blut und die Reserven gehen schnell zur Neige. Obwohl Regierungen Mehr
Speculation is ongoing that a decade-old malaria drug may be one of the key medications slowing down the spread of the novel coronavirus (COVID-19). This dedicated drug is comprised of the chemical chloroquine. Although these chemicals are not legislatively approved Mehr
The Tentamus Group is thoroughly monitoring the COVID-19 pandemic and taking preventative measures to reduce the risk within our global operations. We are pleased to announce that all labs within the Tentamus Group remain open at this point in time. Mehr
Die Tentamus Gruppe beobachtet die COVID-19-Pandemie gründlich und ergreift vorbeugende Maßnahmen, um das Risiko innerhalb unserer globalen Operationen zu verringern. Wir freuen uns bekannt zu geben, dass alle Labore innerhalb der Tentamus Gruppe zu diesem Zeitpunkt weiterhin geöffnet sind. Tentamus Mehr
In October 2020, a complete device qualification of the AscendTM 400 MHz-NMR (Picture 1) used by DSI-pharm was performed to achieve GMP ready status. This was carried out by GMP trained Bruker engineers and included testing the operation of the Mehr
Since the Valsartan scandal in June 2018, there has been a growing interest in the risk assessment of potential traces of toxic nitrosamines in drug substances and products. The Official Medicines Control Laboratories (OMCLs) of the General European OMCL Network Mehr
Adamson Analytical Laboratories is excited to announce that that the capacity for analyses has again been expanded! Stability studies allow you to establish accurate shelf life expectancy for your product, ensuring that it meets quality and safety requirements over it’s Mehr
Ms. Jyothirmai, Director of Megsan Labs, has announced that Megsan now offers special capabilities to support pharmaceutical clients on nitrosamines as per USFDA and EMEA guidelines, using six GCMS and three LCMS devices. Currently, Megsan Labs serve all major Mehr